In a move set to redefine the landscape of pet healthcare, Korean startup AIForPet, a company specializing in innovative pet wellness solutions, has announced its strategic partnership with Proxi Healthcare, a leader in innovative bio and healthcare technologies. This collaboration aims to leverage Proxi Healthcare’s world-class microcurrent technology and AIForPet’s extensive sales and marketing capabilities to drive advancements in the global pet healthcare market.
Founded in 2020, AIForPet revolutionized pet care with its flagship product, ‘TT Care,’ a comprehensive healthcare app designed for pets. With TT Care, pet owners can capture images of their pets’ eyes, skin, and behavior, which are then analyzed by AI algorithms to detect any abnormalities. signs associated with diseases. Moreover, the app facilitates real-time consultations with veterinarians, ensuring quick and efficient care for pets.
Proxi Healthcare, founded in 2019, has made significant strides in various fields such as oral care, beauty care, and medical devices by using proprietary microcurrent technology. Most notably, the company has developed the ‘Tromatz Wave’ technology, which uses microcurrents to effectively remove biofilms without causing harm to the human body or the environment.
Expanding Access to Advanced Pet Healthcare Solutions
Under the terms of the partnership agreement, AIForPet and Proxi Healthcare will collaborate on research and development of new products that use microcurrent technology. In addition, both companies will collaborate on clinical trials, global distribution, and marketing initiatives to accelerate their penetration of the pet health care market.
Commenting on the strategic partnership, AIForPet’s CEO, Eun-ah Heo, emphasized the company’s commitment to delivering innovative pet healthcare solutions. “Recently, many companies, including the pharmaceutical industry, have identified the pet health care industry as a key growth engine. AIForPeT plans to further strengthen its position in the pet care market by introducing various products based on advanced technology,” said Eun-ah Heo.
This collaboration follows AIForPet’s previous strategic agreements, including a partnership with Neoken Bio Co., Ltd., aimed at developing pet nutrition and related products that use high-quality cannabidiol (CBD) extracted from medical cannabis. AIForPet also secured a strategic partnership with American pet platform, Angel Paw earlier this year.
Also read,
Keep tab on the latest news in the Korean startup ecosystem and follow us on LinkedIn, Facebookand Twitter for more exciting updates and insights.
What are your thoughts?
+1
0
Upvote
+1
0
clap your hands
+1
0
clap your hands
+1
0
burning
+1
0
Meh
+1
0
clap your hands
+1
0
